Synergistic effect of glucantime and a liposome-encapsulated muramyl dipeptide analog in therapy of experimental visceral leishmaniasis.
about
Glibenclamide, a blocker of K+(ATP) channels, shows antileishmanial activity in experimental murine cutaneous leishmaniasisActivity of the novel immunomodulatory compound tucaresol against experimental visceral leishmaniasisDual immune modulatory effect of vitamin A in human visceral leishmaniasis.Cyclosporin A treatment converts Leishmania donovani-infected C57BL/10 (curing) mice to a noncuring phenotype.Suppression of both antimony-susceptible and antimony-resistant Leishmania donovani by a bis(benzyl)polyamine analog.
P2860
Synergistic effect of glucantime and a liposome-encapsulated muramyl dipeptide analog in therapy of experimental visceral leishmaniasis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1985
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Synergistic effect of glucanti ...... mental visceral leishmaniasis.
@en
Synergistic effect of glucanti ...... mental visceral leishmaniasis.
@nl
type
label
Synergistic effect of glucanti ...... mental visceral leishmaniasis.
@en
Synergistic effect of glucanti ...... mental visceral leishmaniasis.
@nl
prefLabel
Synergistic effect of glucanti ...... mental visceral leishmaniasis.
@en
Synergistic effect of glucanti ...... mental visceral leishmaniasis.
@nl
P2093
P2860
P1476
Synergistic effect of glucanti ...... mental visceral leishmaniasis.
@en
P2093
Adinolfi LE
Bonventre PF
Eppstein DA
Vander Pas M
P2860
P304
P407
P577
1985-05-01T00:00:00Z